Laporan Laba Rugi (TTM)
Laporan Laba Rugi Aarey Drugs & Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,462 | 2,838 | 3,514 | 4,277 | 5,068 | 5,537 | 4,929 | 5,169 | 4,542 | 3,768 | 4,190 | 3,511 | 3,341 | 3,481 | 3,956 | 4,716 | 5,189 | 5,762 | 4,739 | 4,492 |
| Change (%) | 15.24 | 23.84 | 21.69 | 18.49 | 9.26 | -10.97 | 4.87 | -12.13 | -17.05 | 11.20 | -16.20 | -4.82 | 4.19 | 13.64 | 19.20 | 10.03 | 11.05 | -17.75 | -5.21 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2,366 | 2,726 | 3,378 | 4,081 | 4,890 | 5,325 | 4,721 | 4,911 | 4,373 | 3,607 | 4,039 | 3,351 | 3,196 | 3,337 | 3,819 | 4,575 | 5,013 | 5,590 | 4,621 | 4,363 |
| Change (%) | 15.20 | 23.93 | 20.81 | 19.83 | 8.88 | -11.34 | 4.03 | -10.96 | -17.51 | 11.96 | -17.02 | -4.63 | 4.40 | 14.47 | 19.78 | 9.57 | 11.51 | -17.34 | -5.57 | |
| % of Revenue | 96.09 | 96.05 | 96.12 | 95.42 | 96.50 | 96.16 | 95.77 | 95.01 | 96.27 | 95.74 | 96.40 | 95.46 | 95.65 | 95.84 | 96.54 | 97.01 | 96.60 | 97.01 | 97.49 | 97.12 |
| Gross Operating Profit | 96 | 112 | 136 | 196 | 177 | 212 | 209 | 258 | 169 | 161 | 151 | 159 | 145 | 145 | 137 | 141 | 176 | 172 | 119 | 129 |
| Change (%) | 16.28 | 21.75 | 43.50 | -9.48 | 19.89 | -1.83 | 23.77 | -34.41 | -5.17 | -6.01 | 5.63 | -8.89 | -0.29 | -5.54 | 3.01 | 25.11 | -2.31 | -30.99 | 8.88 | |
| % of Revenue | 3.91 | 3.95 | 3.88 | 4.58 | 3.50 | 3.84 | 4.23 | 4.99 | 3.73 | 4.26 | 3.60 | 4.54 | 4.35 | 4.16 | 3.46 | 2.99 | 3.40 | 2.99 | 2.51 | 2.88 |
| SG&A | 55 | 1 | 4 | 13 | 19 | 13 | 20 | 49 | 3 | -10 | 16 | 20 | 19 | 19 | 14 | 5 | 22 | 22 | 42 | 41 |
| Change (%) | -98.35 | 336.25 | 237.98 | 42.99 | -30.93 | 54.99 | 137.86 | -94.00 | -428.17 | -262.01 | 28.62 | -4.23 | -1.32 | -24.76 | -65.20 | 343.12 | -1.46 | 93.16 | -0.64 | |
| % of Revenue | 2.23 | 0.03 | 0.11 | 0.31 | 0.38 | 0.24 | 0.42 | 0.94 | 0.06 | -0.25 | 0.37 | 0.57 | 0.57 | 0.54 | 0.36 | 0.10 | 0.42 | 0.37 | 0.88 | 0.92 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 2,368 | 2,766 | 3,432 | 4,158 | 4,963 | 5,391 | 4,829 | 5,068 | 4,469 | 3,707 | 4,123 | 3,440 | 3,279 | 3,407 | 3,928 | 4,690 | 5,145 | 5,724 | 4,736 | 4,484 |
| Change (%) | 16.80 | 24.07 | 21.14 | 19.36 | 8.63 | -10.42 | 4.94 | -11.81 | -17.05 | 11.21 | -16.57 | -4.66 | 3.89 | 15.29 | 19.41 | 9.69 | 11.26 | -17.25 | -5.32 | |
| % of Revenue | 96.19 | 97.48 | 97.66 | 97.22 | 97.93 | 97.36 | 97.97 | 98.03 | 98.39 | 98.39 | 98.40 | 97.97 | 98.14 | 97.86 | 99.29 | 99.46 | 99.15 | 99.34 | 99.94 | 99.82 |
| Operating Income | 94 | 72 | 82 | 119 | 105 | 146 | 100 | 102 | 73 | 61 | 67 | 71 | 62 | 75 | 28 | 25 | 44 | 38 | 3 | 8 |
| Change (%) | -23.85 | 15.08 | 44.66 | -11.89 | 39.45 | -31.47 | 1.49 | -28.16 | -16.85 | 10.09 | 6.41 | -12.90 | 20.21 | -62.20 | -9.77 | 73.20 | -13.86 | -91.92 | 163.69 | |
| % of Revenue | 3.81 | 2.52 | 2.34 | 2.78 | 2.07 | 2.64 | 2.03 | 1.97 | 1.61 | 1.61 | 1.60 | 2.03 | 1.86 | 2.14 | 0.71 | 0.54 | 0.85 | 0.66 | 0.06 | 0.18 |
| Interest Expense | -21 | -22 | -23 | -24 | -21 | -20 | -18 | -21 | -20 | -22 | -25 | -29 | -36 | -39 | -42 | -44 | -45 | -43 | -40 | -41 |
| Change (%) | 1.55 | 6.59 | 5.09 | -12.52 | -5.57 | -9.90 | 14.56 | -5.22 | 11.18 | 16.07 | 13.66 | 23.38 | 9.82 | 7.24 | 5.77 | 1.37 | -3.54 | -7.42 | 2.01 | |
| % of Revenue | -0.87 | -0.77 | -0.66 | -0.57 | -0.42 | -0.36 | -0.37 | -0.40 | -0.43 | -0.58 | -0.61 | -0.82 | -1.07 | -1.12 | -1.06 | -0.94 | -0.87 | -0.75 | -0.85 | -0.91 |
| Net Income | 58 | 61 | 65 | 77 | 85 | 87 | 66 | 48 | 41 | 27 | 38 | 37 | 24 | 29 | 47 | 52 | 60 | 57 | 40 | 42 |
| Change (%) | 5.19 | 6.74 | 17.65 | 10.41 | 2.89 | -24.72 | -26.22 | -14.98 | -35.35 | 41.85 | -2.00 | -36.11 | 22.36 | 62.12 | 10.98 | 15.62 | -5.06 | -29.48 | 3.29 | |
| % of Revenue | 2.36 | 2.15 | 1.85 | 1.79 | 1.67 | 1.57 | 1.33 | 0.94 | 0.91 | 0.71 | 0.90 | 1.05 | 0.71 | 0.83 | 1.18 | 1.10 | 1.16 | 0.99 | 0.85 | 0.93 |
Source: Capital IQ
